• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
TGIF1 functions as a tumor suppressor in pancreatic ductal adenocarcinoma.TGIF1 在胰腺导管腺癌中作为一种肿瘤抑制因子发挥作用。
EMBO J. 2019 Jul 1;38(13):e101067. doi: 10.15252/embj.2018101067. Epub 2019 May 31.
2
Loss of the transcriptional repressor TGIF1 results in enhanced Kras-driven development of pancreatic cancer.转录抑制因子 TGIF1 的缺失导致 Kras 驱动的胰腺癌发生发展增强。
Mol Cancer. 2019 May 20;18(1):96. doi: 10.1186/s12943-019-1023-1.
3
Loss of Somatostatin Receptor Subtype 2 Promotes Growth of KRAS-Induced Pancreatic Tumors in Mice by Activating PI3K Signaling and Overexpression of CXCL16.生长抑素受体亚型 2 缺失通过激活 PI3K 信号和 CXCL16 的过表达促进小鼠 KRAS 诱导的胰腺肿瘤生长。
Gastroenterology. 2015 Jun;148(7):1452-65. doi: 10.1053/j.gastro.2015.02.009. Epub 2015 Feb 13.
4
Aggressive pancreatic ductal adenocarcinoma in mice caused by pancreas-specific blockade of transforming growth factor-beta signaling in cooperation with active Kras expression.胰腺特异性阻断转化生长因子-β信号通路并联合激活型Kras表达导致小鼠侵袭性胰腺导管腺癌。
Genes Dev. 2006 Nov 15;20(22):3147-60. doi: 10.1101/gad.1475506.
5
Oncogenic KRAS Reduces Expression of FGF21 in Acinar Cells to Promote Pancreatic Tumorigenesis in Mice on a High-Fat Diet.致癌性 KRAS 降低高脂肪饮食小鼠胰岛细胞中 FGF21 的表达,从而促进胰腺肿瘤发生。
Gastroenterology. 2019 Nov;157(5):1413-1428.e11. doi: 10.1053/j.gastro.2019.07.030. Epub 2019 Jul 25.
6
Lunatic Fringe is a potent tumor suppressor in Kras-initiated pancreatic cancer.边缘型精神错乱蛋白是Kras引发的胰腺癌中的一种强效肿瘤抑制因子。
Oncogene. 2016 May 12;35(19):2485-95. doi: 10.1038/onc.2015.306. Epub 2015 Aug 17.
7
miR-802 Suppresses Acinar-to-Ductal Reprogramming During Early Pancreatitis and Pancreatic Carcinogenesis.miR-802 抑制胰腺炎早期和胰腺癌发生过程中的腺泡到导管的重编程。
Gastroenterology. 2022 Jan;162(1):269-284. doi: 10.1053/j.gastro.2021.09.029. Epub 2021 Sep 20.
8
Oncogenic ERBB2 aberrations and KRAS mutations cooperate to promote pancreatic ductal adenocarcinoma progression.致癌性 ERBB2 异常和 KRAS 突变协同促进胰腺导管腺癌的进展。
Carcinogenesis. 2020 Mar 13;41(1):44-55. doi: 10.1093/carcin/bgz086.
9
Smad4 is dispensable for normal pancreas development yet critical in progression and tumor biology of pancreas cancer.Smad4对于正常胰腺发育并非必需,但在胰腺癌的进展和肿瘤生物学中至关重要。
Genes Dev. 2006 Nov 15;20(22):3130-46. doi: 10.1101/gad.1478706.
10
Cell of origin affects tumour development and phenotype in pancreatic ductal adenocarcinoma.起源细胞影响胰腺导管腺癌的肿瘤发生和表型。
Gut. 2019 Mar;68(3):487-498. doi: 10.1136/gutjnl-2017-314426. Epub 2018 Jan 23.

引用本文的文献

1
Discovering the Potential Role of the C2 DUSP2+ MCs Subgroup in Lung Adenocarcinoma.发现C2 DUSP2+肥大细胞亚群在肺腺癌中的潜在作用。
Transl Oncol. 2025 Apr;54:102295. doi: 10.1016/j.tranon.2025.102295. Epub 2025 Feb 26.
2
Metastatic organotropism in small cell lung cancer.小细胞肺癌的转移器官嗜性
bioRxiv. 2025 Jan 24:2024.10.07.617066. doi: 10.1101/2024.10.07.617066.
3
Inferring regulators of cell identity in the human adult pancreas.推断人类成年胰腺中细胞身份的调节因子。
NAR Genom Bioinform. 2023 Jul 10;5(3):lqad068. doi: 10.1093/nargab/lqad068. eCollection 2023 Sep.
4
Mechanistic elucidation of Juglanthraquinone C targeting breast Cancer: A network Pharmacology-based investigation.胡桃醌C靶向乳腺癌的作用机制阐释:基于网络药理学的研究
Saudi J Biol Sci. 2023 Jul;30(7):103705. doi: 10.1016/j.sjbs.2023.103705. Epub 2023 Jun 15.
5
Antagonism between Prdm16 and Smad4 specifies the trajectory and progression of pancreatic cancer.Prdm16 和 Smad4 之间的拮抗作用决定了胰腺癌的轨迹和进展。
J Cell Biol. 2023 Apr 3;222(4). doi: 10.1083/jcb.202203036. Epub 2023 Feb 24.
6
Epithelial to Mesenchymal Transition as Mechanism of Progression of Pancreatic Cancer: From Mice to Men.上皮-间质转化作为胰腺癌进展机制:从小鼠到人类
Cancers (Basel). 2022 Nov 24;14(23):5797. doi: 10.3390/cancers14235797.
7
NF1 loss of function as an alternative initiating event in pancreatic ductal adenocarcinoma.NF1 功能丧失作为胰腺导管腺癌的另一种起始事件。
Cell Rep. 2022 Nov 8;41(6):111623. doi: 10.1016/j.celrep.2022.111623.
8
Epithelial-mesenchymal transition: The history, regulatory mechanism, and cancer therapeutic opportunities.上皮-间质转化:历史、调控机制及癌症治疗机遇
MedComm (2020). 2022 May 18;3(2):e144. doi: 10.1002/mco2.144. eCollection 2022 Jun.
9
Silencing of histone deacetylase 3 suppresses the development of esophageal squamous cell carcinoma through regulation of miR-494-mediated TGIF1.组蛋白去乙酰化酶3的沉默通过调控miR-494介导的TGIF1抑制食管鳞状细胞癌的发展。
Cancer Cell Int. 2022 May 16;22(1):191. doi: 10.1186/s12935-022-02581-3.
10
Loss of IRF7 accelerates acute myeloid leukemia progression and induces VCAM1-VLA-4 mediated intracerebral invasion.IRF7 的缺失会加速急性髓系白血病的进展,并诱导 VCAM1-VLA-4 介导的颅内浸润。
Oncogene. 2022 Apr;41(16):2303-2314. doi: 10.1038/s41388-022-02233-w. Epub 2022 Mar 7.

本文引用的文献

1
Twist1 Activation in Muscle Progenitor Cells Causes Muscle Loss Akin to Cancer Cachexia.肌祖细胞中 Twist1 的激活导致类似于癌症恶病质的肌肉丢失。
Dev Cell. 2018 Jun 18;45(6):712-725.e6. doi: 10.1016/j.devcel.2018.05.026.
2
JUNB governs a feed-forward network of TGFβ signaling that aggravates breast cancer invasion.JUNB 调控 TGFβ 信号的前馈网络,从而加重乳腺癌的侵袭。
Nucleic Acids Res. 2018 Feb 16;46(3):1180-1195. doi: 10.1093/nar/gkx1190.
3
TGF-β Tumor Suppression through a Lethal EMT.通过致死性上皮-间质转化实现的转化生长因子-β肿瘤抑制作用
Cell. 2016 Feb 25;164(5):1015-30. doi: 10.1016/j.cell.2016.01.009. Epub 2016 Feb 18.
4
Homeodomain proteins: an update.同源结构域蛋白:最新进展
Chromosoma. 2016 Jun;125(3):497-521. doi: 10.1007/s00412-015-0543-8. Epub 2015 Oct 13.
5
RUNX3 Controls a Metastatic Switch in Pancreatic Ductal Adenocarcinoma.RUNX3调控胰腺导管腺癌中的转移开关。
Cell. 2015 Jun 4;161(6):1345-60. doi: 10.1016/j.cell.2015.04.048. Epub 2015 May 21.
6
TGIF governs a feed-forward network that empowers Wnt signaling to drive mammary tumorigenesis.TGIF调控一个前馈网络,该网络增强Wnt信号传导以驱动乳腺肿瘤发生。
Cancer Cell. 2015 Apr 13;27(4):547-60. doi: 10.1016/j.ccell.2015.03.002.
7
Disruption of the PHRF1 Tumor Suppressor Network by PML-RARα Drives Acute Promyelocytic Leukemia Pathogenesis.PML-RARα对PHRF1肿瘤抑制网络的破坏驱动急性早幼粒细胞白血病发病机制。
Cell Rep. 2015 Feb 17;10(6):883-890. doi: 10.1016/j.celrep.2015.01.024. Epub 2015 Feb 12.
8
Depletion of carcinoma-associated fibroblasts and fibrosis induces immunosuppression and accelerates pancreas cancer with reduced survival.耗竭癌相关成纤维细胞和纤维化会诱导免疫抑制,并加速胰腺癌发展,降低患者生存率。
Cancer Cell. 2014 Jun 16;25(6):719-34. doi: 10.1016/j.ccr.2014.04.005. Epub 2014 May 22.
9
MAPK signaling is required for dedifferentiation of acinar cells and development of pancreatic intraepithelial neoplasia in mice.MAPK 信号通路对于小鼠腺泡细胞去分化和胰腺上皮内瘤形成的发展是必需的。
Gastroenterology. 2014 Mar;146(3):822-834.e7. doi: 10.1053/j.gastro.2013.11.052. Epub 2013 Dec 6.
10
Identification of PHRF1 as a tumor suppressor that promotes the TGF-β cytostatic program through selective release of TGIF-driven PML inactivation.鉴定 PHRF1 为一种肿瘤抑制因子,通过选择性释放 TGIF 驱动的 PML 失活来促进 TGF-β 细胞静止程序。
Cell Rep. 2013 Aug 15;4(3):530-41. doi: 10.1016/j.celrep.2013.07.009. Epub 2013 Aug 1.

TGIF1 在胰腺导管腺癌中作为一种肿瘤抑制因子发挥作用。

TGIF1 functions as a tumor suppressor in pancreatic ductal adenocarcinoma.

机构信息

Cellular and Molecular Pathogenesis Division, Department of Pathology and Massey Cancer Center, Virginia Commonwealth University, Richmond, VA, USA.

Cancer Institute, University of Mississippi Medical Center, Jackson, MS, USA.

出版信息

EMBO J. 2019 Jul 1;38(13):e101067. doi: 10.15252/embj.2018101067. Epub 2019 May 31.

DOI:10.15252/embj.2018101067
PMID:31268604
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6601038/
Abstract

A prominent function of TGIF1 is suppression of transforming growth factor beta (TGF-β) signaling, whose inactivation is deemed instrumental to the progression of pancreatic ductal adenocarcinoma (PDAC), as exemplified by the frequent loss of the tumor suppressor gene SMAD4 in this malignancy. Surprisingly, we found that genetic inactivation of Tgif1 in the context of oncogenic Kras, Kras , culminated in the development of highly aggressive and metastatic PDAC despite de-repressing TGF-β signaling. Mechanistic experiments show that TGIF1 associates with Twist1 and inhibits Twist1 expression and activity, and this function is suppressed in the vast majority of human PDACs by Kras /MAPK-mediated TGIF1 phosphorylation. Ablating Twist1 in Kras ;Tgif1 mice completely blunted PDAC formation, providing the proof-of-principle that TGIF1 restrains Kras -driven PDAC through its ability to antagonize Twist1. Collectively, these findings pinpoint TGIF1 as a potential tumor suppressor in PDAC and further suggest that sustained activation of TGF-β signaling might act to accelerate PDAC progression rather than to suppress its initiation.

摘要

TGIF1 的一个主要功能是抑制转化生长因子β(TGF-β)信号,其失活被认为对胰腺导管腺癌(PDAC)的进展至关重要,例如这种恶性肿瘤中频繁缺失肿瘤抑制基因 SMAD4。令人惊讶的是,我们发现,尽管 TGF-β信号被解除抑制,但在致癌性 Kras 背景下遗传失活 Tgif1 最终导致高度侵袭性和转移性 PDAC 的发展。机制实验表明,TGIF1 与 Twist1 结合并抑制 Twist1 的表达和活性,而这种功能在绝大多数人类 PDAC 中被 Kras/MAPK 介导的 TGIF1 磷酸化所抑制。在 Kras;Tgif1 小鼠中消除 Twist1 完全阻止了 PDAC 的形成,提供了 TGIF1 通过拮抗 Twist1 来抑制 Kras 驱动的 PDAC 的原理证明。总的来说,这些发现指出 TGIF1 是 PDAC 中的一个潜在肿瘤抑制因子,并进一步表明 TGF-β 信号的持续激活可能加速 PDAC 的进展,而不是抑制其起始。